CESS Cells

If you intend to use this Cytion cell line solely for internal research at a single research site, please complete and sign the Material Transfer Agreement (MTA) and submit it along with your order. For any commercial applications – including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies – please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.

Item number Size Datasheet Manual SDS Delivery time Quantity Price
CYT-300262 1 each -

5-10 business days*

430.00€
 
Categories: Leukemia cell lines Description: The CESS cell line is a B lymphoblastoid cell line... more
Product information "CESS Cells"
Categories: Leukemia cell lines Description: The CESS cell line is a B lymphoblastoid cell line derived from a human patient with leukemia. This cell line is commonly used to study immunoglobulin production, particularly IgG secretion, due to its strong response to cytokine stimulation. CESS cells are EBV-transformed and exhibit surface markers characteristic of mature B cells, such as CD19 and CD38. They express the sIgG1 class of immunoglobulins and serve as a model for studying B cell differentiation and function, including immune responses regulated by cytokines like interleukin-6 (IL-6), also known as B-cell stimulation factor 2 (BSF-2). IL-6 plays a crucial role in stimulating immunoglobulin production in CESS cells, making them a valuable model for investigating B cell responses in immunological research. Additionally, CESS cells have been instrumental in studies focusing on cell signaling and apoptosis. Notably, these cells have been shown to produce and respond to Nerve Growth Factor (NGF) through an autocrine signaling mechanism, expressing both high- and low-affinity NGF receptors. Blocking NGF signaling with antibodies or specific inhibitors induces apoptosis in CESS cells, characterized by Bcl-2 phosphorylation and activation of the p38 MAPK pathway. This makes CESS cells an important model for understanding the molecular mechanisms of B cell survival and apoptosis, particularly in the context of NGF signaling and its regulation of the Bcl-2 family proteins. Organism: Human Tissue: Peripheral blood Disease: Acute myeloid leukemia Synonyms: Cess Gender: Male Ethnicity: European Morphology: Lymphoblast Growth Properties: Suspension Citation: CESS (Cytion catalog number 300262) Biosafety Level: 1 Ncbi_ Taxid: 9606.0 Cellosaurus Accession: CVCL_0209 Viruses: Transformed by EBV Products: IL-2 after induction with TRF (T cell-replacing factor) Culture Medium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) Supplements: Supplement the medium with 10% FBS Subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. Seeding Density: 1 x 104 cells/cm2 is recommended Fluid Renewal: 2 to 3 times per week Post Thaw Recovery: Allow the cells to recover from the freezing process for at least 48 hours. Freeze Medium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Thawing And Culturing Cells: Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks, for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes. Sterility: Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. Safety Precautions: When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Warranty: We stand by the promise of delivering products with high cell viability and robust culture performance. To achieve the best results, please make sure you follow the storage and culture instructions detailed in the product information sheet closely. Your adherence to these guidelines is key to success. Subject To Material Transfer Agreements: If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement. Required Product 1: 820700a Required Product 3: 860015.0 Required Product 4: 830100.0
Supplier: Cytion
Supplier-Nr: 300262

Properties

Host: Human
Species reactivity: human

Database Information

Handling & Safety

Storage: Liquid nitrogen
Shipping: -80°C (International: -80°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CESS Cells"
Write a review
or to review a product.
Viewed